KCNA5 and atrial fibrillation: Furthermore, Lu et al. reported that aldosterone enhanced the expression of Kv1.5, a promising target for the treatment of AF, by activating ROS-dependent phosphorylation of Smad 2/3 and ERK 1/2 in a rat AF model (116).